Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Formulierung:
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Sequenz:
Synthetic peptide located within the following region: ILETEAADLGNDERSKKPGTPGTPGSHDLETALRRLSLRRENYLSERRFF
Target-Kategorie:
TRAK1
25 ug of the indicated Human whole cell extracts was loaded onto a 6-18% SDS-PAGE gel. 1 ug/ml of the antibody was used in this experiment. Isoforms containing the peptide sequence are present at ~77 and ~64 kDa.
Sample Type: HCT15, Antibody dilution: 1.0 ug/ml. There is BioGPS gene expression data showing that TRAK1 is expressed in HCT15.
Sample Type: Hela, Antibody dilution: 1.0 ug/ml. TRAK1 is supported by BioGPS gene expression data to be expressed in HeLa.
Sample Type: HepG2, Antibody dilution: 1.0 ug/ml. TRAK1 is strongly supported by BioGPS gene expression data to be expressed in Human HepG2 cells.
Sample Type: HT1080, Antibody dilution: 1.0 ug/ml. There is BioGPS gene expression data showing that TRAK1 is expressed in HT1080.
Positive control (+): HepG2 Cell Lysate (HG), Negative control (-): Human Liver Tumor (T-LI), Antibody concentration: 1 ug/ml.
WB Suggested Anti-TRAK1 Antibody Titration: 0.2-1 ug/ml, ELISA Titer: 1:1562500, Positive Control: HT1080 cell lysate. There is BioGPS gene expression data showing that TRAK1 is expressed in HT1080.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten